MedTrace Logo

Comparison of the Efficacy and Safety of Oliceridine and Sufentanil in Patients Undergoing Outpatient Hysteroscopy

NCT07713134 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2026-07-20

No results posted yet for this study

Summary

This study aimed to investigate the safety and efficacy of oliceridine compared with sufentanil in outpatient hysteroscopy.

Conditions

  • Hysteroscopy
  • Analgeisa

Interventions

DRUG

Sufentanil

sufentanil is diluted to a 5μg/ml injection solution

DRUG

Oliceridine

Oliceridine is diluted to a 1mg/kg injection solution

Sponsors & Collaborators

  • Tangshan Maternal and Child Health Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-01
Primary Completion
2026-05-20
Completion
2026-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07713134 on ClinicalTrials.gov